Sherbrooke Park Advisers’s Halozyme HALO Stock Holding History

Sherbrooke Park Advisers’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,384	Closed	-$332K	–	607
2025 Q2	$332K	Buy	+6,384	New	+$363K	0.14%	282

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sherbrooke Park Advisers's HALO Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of Halozyme (HALO) in Q3 2025, closing a stake of 6,384 shares — an estimated $332K sold.

Sherbrooke Park Advisers first reported a position in HALO in Q2 2025 and held it in 1 quarter. The position peaked at $332K in Q2 2025. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

Sherbrooke Park Advisers reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
Sherbrooke Park Advisers sold 6,384 Halozyme shares in Q3 2025, an estimated $332K.
Sherbrooke Park Advisers first reported a position in Halozyme in Q2 2025 and held it in 1 quarter.
Sherbrooke Park Advisers's Halozyme position peaked at $332K in Q2 2025.
602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.